Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 43 (NPM1P43) is classified as a pseudogene of the nucleophosmin 1 (NPM1) gene in humans. It does not encode a functional protein and is not considered a therapeutic target such as a receptor, enzyme, transporter, or other biologically active molecule. Pseudogenes are typically non-functional sequences, and although dozens of NPM1 pseudogenes have been identified in the human genome, they do not share the biological activities, classification, or disease relevance that the true NPM1 protein does. Therapeutic targeting of NPM1 pseudogenes (such as NPM1P43) is not described in scientific literature. Therapies and diagnostics focus on the canonical NPM1 gene and protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 43 (NPM1P43).